ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 83 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $90,000 | -4.3% | 12,092 | -25.6% | 0.00% | -100.0% |
| Q4 2019 | $94,000 | -2.1% | 16,250 | -11.0% | 0.00% | 0.0% |
| Q3 2019 | $96,000 | +7.9% | 18,250 | +23.7% | 0.00% | 0.0% |
| Q2 2019 | $89,000 | -39.0% | 14,750 | -9.2% | 0.00% | 0.0% |
| Q1 2019 | $146,000 | +8.1% | 16,250 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $135,000 | -39.7% | 16,250 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $224,000 | +45.5% | 16,250 | -15.6% | 0.00% | +100.0% |
| Q2 2018 | $154,000 | +6.2% | 19,250 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $145,000 | +30.6% | 19,250 | +18.5% | 0.00% | 0.0% |
| Q4 2017 | $111,000 | -48.1% | 16,250 | -45.2% | 0.00% | -50.0% |
| Q3 2017 | $214,000 | – | 29,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,877,305 | $10,025,000 | 5.86% |
| Prosight Management, LP | 1,210,800 | $6,466,000 | 3.46% |
| Perceptive Advisors | 11,350,085 | $60,609,000 | 1.76% |
| JOHNSON & JOHNSON | 394,834 | $2,108,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $3,738,000 | 0.46% |
| APOGEM CAPITAL LLC | 85,091 | $454,000 | 0.45% |
| 683 Capital Management, LLC | 700,000 | $3,738,000 | 0.29% |
| EAM Investors, LLC | 233,638 | $1,248,000 | 0.27% |
| Verition Fund Management LLC | 4,804,478 | $12,840,828 | 0.14% |
| WOODSTOCK CORP | 129,179 | $690,000 | 0.10% |